SCM
ZYNE

Segantii Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Segantii Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,500
Closed -$291K – 291
2017
Q1 		$291K Buy
+14,500
New +$291K 0.05% 106